Elanco Animal Health (ELAN) Other Working Capital Changes (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Other Working Capital Changes came in at $263.0 million in Q1 2026, up 2730.0% year-on-year from $9.3 million in Q1 2025, and up 278.91% quarter-over-quarter from -$147.0 million in Q4 2025.
Elanco Animal Health (ELAN) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Other Working Capital Changes across 10 years of filings, most recently posting $263.0 million for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $263.0 million, up 2730.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $252.0 million (up 2700.0% YoY), and the FY2025 annual result was -$21.0 million, down 90.91% from the prior year.
- Other Working Capital Changes came in at $263.0 million for Q1 2026 at Elanco Animal Health, up from -$147.0 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $434.0 million in Q3 2023 to a low of -$435.0 million in Q4 2023.
- The 5-year median for Other Working Capital Changes is -$9.0 million (2024), against an average of $20.6 million.
- Across the five-year window, Other Working Capital Changes sank 5600.0% in 2022 and jumped 2730.0% in 2026, its largest moves.
- Elanco Animal Health's Other Working Capital Changes stood at -$276.0 million in 2022, then tumbled by 57.61% to -$435.0 million in 2023, then jumped by 108.74% to $38.0 million in 2024, then sank by 486.84% to -$147.0 million in 2025, then jumped by 278.91% to $263.0 million in 2026.
- The last three Other Working Capital Changes figures came in at $263.0 million (Q1 2026), -$147.0 million (Q4 2025), and -$59.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 263.00 Mn |
| Mar 31, 2026 | 263.00 Mn |
| Dec 31, 2025 | -147.00 Mn |
| Dec 31, 2025 | -147.00 Mn |
| Sep 30, 2025 | -59.00 Mn |
| Sep 30, 2025 | -59.00 Mn |
| Jun 30, 2025 | 195.00 Mn |
| Jun 30, 2025 | 195.00 Mn |
| Mar 31, 2025 | -10.00 Mn |
| Mar 31, 2025 | -10.00 Mn |
| Dec 31, 2024 | 38.00 Mn |
| Dec 31, 2024 | 38.00 Mn |
| Sep 30, 2024 | -10.00 Mn |
| Sep 30, 2024 | -10.00 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Mar 31, 2024 | -30.00 Mn |
| Mar 31, 2024 | -30.00 Mn |
| Dec 31, 2023 | -435.00 Mn |
| Dec 31, 2023 | -435.00 Mn |